Client News

MagForce AG Publishes Shareholder Letter

Newron Reports Top-Line Results from its STARS Study Evaluating Sarizotan in Patients with Rett Syndrome

Verona Pharma plc: Operational Update and Financial Results for the Three Months Ended March 31, 2020

InflaRx Reports Full Year 2019 Financial & Operating Results

Secarna Pharmaceuticals enters into cooperation with Guangzhou’s Sun Yat-sen University to develop a treatment for SARS-CoV-2 viral infections

MagForce AG: MagForce USA, Inc. has received FDA Approval to proceed with its Streamlined Trial Protocol for the next Stage of Pivotal U.S. Single-Arm Study for the Focal Ablation of Intermediate Risk Prostate Cancer with the NanoTherm Therapy System

CEVEC Announces the Launch of the ELEVECTA® Platform – the Stable Producer Cell Line Technology for AAV Gene Therapy Vectors

Heidelberg Pharma AG Raises EUR 14.4 Million From Private Placement

Heidelberg Pharma AG Plans Capital Increase to Fund Its ATAC Development Program

4basebio AG Reports positive Financial Results for Fiscal Year 2019 – Financial Guidance Met